Awarded
IG POLYVALENTE HUMAINE IV 50 MG / ML (5%) POUDRE ET SOLVANT - Indication en présence d'AC anti Ig A
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- TAKEDA FRANCE SAS
- Contract value
- €7,772,215
- Published
- 29 Apr 2025
- Awarded
- 3 Feb 2025
- Contract start
- 1 Jun 2025
- Contract end
- 31 May 2029stated
- Region
- Rhône